Why the study?
Do augmental and pelvic osteotomies other than PAO have a place in the current treatment algorithm for the dysplastic hip?
Population
Patients with developmental dysplasia of the hip
Design
Review
Follow-up
minimum 11 years
Authors
Loading...
Other osteotomies may retain niche roles in hip dysplasia; leaves open whether PAO should supplant all alternatives.
Do augmental and pelvic osteotomies other than PAO have a place in the current treatment algorithm for the dysplastic hip?
This review assesses the long-term outcomes of non-PAO pelvic osteotomies for hip dysplasia to determine their current role in joint preservation.
Shibata et al. (2015) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: